Achieving optimal blood sugar control after a meal is a great challenge that often seems to be a random turn of events one can rarely predict. This represents a reality that those living with type 1 diabetes are very familiar with. Here are the key messages from Lorraine Anderson’s, RD, CDE presentation on this topic … Read moreDiabetes Canada 2019 – There is no easy way to predict blood sugar fluctuations following a meal
At the EASD congress held in late September 2019 in Europe, a new continuous glucose monitoring system was presented by Nemaura Medical. This new device is called SugarBEAT® and is non-invasive, ie no needles are needed to install it. Indeed, it is in the form of a disposable adhesive patch to wear on the arm. … Read moreSugarBEAT®: A continuous glucose meter without needle
As of October 22nd, 2019, Novonordisk’s ultra-fast insulin Fiasp® is now approved for insulin pumps in the United States. This insulin analogue, already approved in Quebec for people who inject insulin with a pen or syringe, is a fast-acting insulin that is even faster than the usual rapid insulins (Novorapid®, Apidra®, Humalog®). The faster mode … Read moreFiasp® insulin approved for insulin pumps in the United States
Type 1 diabetes is often diagnosed in childhood. In most cases, parents are directly responsible for their child’s medical care until the latter becomes progressively more independent in their teen years. But how can we ensure a smooth transition from paediatric care to adult care so that young people can become self-sufficient in their treatment? Dr. Jennifer … Read moreDiabetes Canada 2019 – Adolescence: How Development Influences Involvement in Type 1 Diabetes Treatment
Anne Jarry is a professor at Université de Montréal’s School of Optometry. She lost her sight at the age of 24 and has been living with type 1 diabetes since she was nine years old. Part of her work involves testing new technologies to make them accessible to people with visual disabilities. Today, she’ll be telling us about … Read moreAn Interview with Anne Jarry : Digital Tools Are Revolutionizing the Treatment of Diabetes
Continuous glucose monitoring (CGM) systems give more information than capillary blood sugar meters. This information is displayed directly on the reader, allowing the user to quickly take proper action and anticipate low blood sugar episodes, and is also used in reports to help better analyze blood sugar trends over a certain period, for example two … Read moreNew recommendations for continuous glucose monitoring systems and time in range
Cannabis, also known as marijuana, is now legalized in Canada, but its effects in relation to diabetes remain poorly known. Previous studies have found links between cannabis use and improved insulin sensitivity in people living with type 2 diabetes. Which means that cannabis use may increase the body’s ability to metabolize sugar in the blood … Read moreCan cannabis use be linked to a risk of diabetic ketoacidosis?